Daniel Rotrosen

Title: The Innovative Contributions of Daniel Rotrosen

Introduction

Daniel Rotrosen is a notable inventor based in Takoma Park, MD (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptide derivatives that have therapeutic applications. With a total of 2 patents, his work focuses on addressing inflammatory diseases through innovative approaches.

Latest Patents

Rotrosen's latest patents include "Peptide derivatives of cytochrome b.sub.558 and their use as medicaments." These peptide derivatives exhibit inhibitory activity on the enzyme systems involved in the oxidative burst of human phagocytic cells. The sequences consist of six and seven amino acid peptide sequences derived from human cytochrome b.sub.558. These derivatives hold promise for use in medicaments aimed at treating inflammatory diseases. Another patent under his name also focuses on peptide derivatives of cytochrome b.sub.558, emphasizing a specific sequence of carboxyl-terminal amino acids. This innovation further supports the potential for therapeutic applications in inflammatory conditions.

Career Highlights

Daniel Rotrosen is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding of peptide derivatives and their medicinal uses. His research has contributed to the development of new treatment options for patients suffering from inflammatory diseases.

Collaborations

Some of his notable coworkers include Harry L Malech and Karen J Lomax. Their collaborative efforts have enhanced the research and development of innovative medicinal solutions.

Conclusion

Daniel Rotrosen's contributions to the field of medicinal chemistry through his patents and collaborative work highlight his commitment to advancing healthcare solutions. His innovative approaches to treating inflammatory diseases demonstrate the importance of research and development in the medical field.